Should we perform routine psa testing in all patients over 50 years of age?
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v38i2.580Keywords:
Ask the ExpertAbstract
A healthy 55-year-old man with no family history of prostate disease and no urinary symptoms comes to the clinic for a routine check-up and blood tests. Should we perform routine PSA testing in all patients over 50 years of age?
Downloads
References
Vertosick EA, Poon BY, Vickers AJ. Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2014;192(3):724-728. DOI: https://doi.org/10.1016/j.juro.2014.03.032
National Comprehensive Cancer Network [Internet]. Fort Washington, PA: NCCN; 2018 [consulta 06/08/2018]. Disponible en: https://www.nccn.org
De Vita VT, Lawrence TS, Rosenberg SA, eds. Principles and practice of oncology. 8th ed. Philadelphia: Lippincott Wiliams & Wilkins; 2008. 2 v.
Ilic D, Neuberger MM, Djulbegovic M, y col. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1):CD004720. DOI: https://doi.org/10.1002/14651858.CD004720.pub3
Eastham J, Vickers A, Lilja H, et al. Prostate cancer screening guidelines [internet]. New York: Memorial Sloan Kettering Cancer Center; [2018] [consulta 06/08/2018]. Disponible en: https://www.mskcc.org/cancer-care/types/prostate/screening/screening-guidelines-prostate
United States Preventive Services Task Force. Prostate cancer screening final recommendation [Internet]. Rockville, MD: USPSTF; 2018 [consulta 06/08/2018]. Disponible en: https://screeningforprostatecancer.org/
Martin RM, Donovan JL, Turner EL, et al. Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial. JAMA. 2018;319(9):883-895. DOI: https://doi.org/10.1001/jama.2018.0154
Cosma G, McArdle SE, Reeder S, et al. Identifying the presence of prostate cancer in individuals with PSA levels <20 ng ml(-1) using computational data extraction analysis of high dimensional peripheral blood flow cytometric phenotyping data. Front Immunol. 2017;8:1771.Conflictos de interés: el autor declara no tener conflictos de interés. DOI: https://doi.org/10.3389/fimmu.2017.01771
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Revista del Hospital Italiano de Buenos Aires
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
